Products
Community
Markets
News
Brokers
More

Markets
Mexico
Stocks
Health Technology
Pharmaceuticals: Major
REGN
Ideas

REGENERON PHARMACEUTICALS INC

No trades

See on Supercharts

Overview Financials News

Ideas

Discussions Technicals Forecast Seasonals Bonds

REGN trade ideas

REGN - Potential Long Trade MTHLY: Developing MACD bullish devergence. September XOver @295.87 - October XOver @ 282.03 (below current levels). Potential minor tail formation. Price at suppot level. WKLY: OBV bullish devergence. IS blue Daily: IS Blue Most OBV POCs are above current levels. If this goes up it could go up pretty solidly.

Long

by depfa

Updated

REGN Possiblle bullish after retracement and buy at 294.55, another bullish after further retracement at resistance.

Long

by UnknownUnicorn4572241

Published

REGN LONG 2 CASES POSSIBLE..as usual UP or DOWN.. Short term Long for REGN .. tgt 325-331 If dumps then we may touch 240 and 215 Currently long at 310. Stop 297.

Long

by MONEYMENOW

Published

REGN - Fibonacci Retracement 4 hr chart I've opened May 345 / June 340 Call Diagonal Spread.

Long

by SubGenius

Updated

$REGN Difficult to be bullish on Regeneron Pharma Inc. Regeneron is just another victim of the outflows from healthcare, there is nothing positive to cling to on the chart. As earnings approaches price action can only indicate that more selling is imminent, short for now and look for long on test of support or trend line.

Short

by RedHotStocks

Published

FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic REGN: Regeneron Pharmaceuticals, Inc. 2019-03-11 15:44:00 FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents - PR Newswire

Long

by RocketTickers

Published

$REGN Potential problem potential mini H&S developing on the daily near top of trend line. MACD suggest not enough strength to break TL. Watching for a break of the neckline.

by Hearsjonny

Published

regn regn over 124.50 we fly

Long

by EminiOs

Published

$REGN Short swing Previous channel resistance, i can't help but think this will retest 400 and the 50 ema on daily.

Short

by Hearsjonny

Published

$REGN BULL FLAG NASDAQ:REGN BULL FLAG CONTINUATION

by jarroddewan101

Published

regn regn

by EminiOs

Published

Short REGN (Once 340 confirms a break)Watch very congested area at 340, short it once that is broken.

Short

by KeyTrade

Published

Short REGN from 365 (Potential bounce)to 183 Potential bounce to 365 area before falling again, target price at 183

Short

by KeyTrade

Published

Really beautiful buying setup - REGN Will wait patiently for REGN to get into the buying box -- expect it to arrive last august

Long

by Astatine

Updated

[REGN] phase 1 -> phase 2 The price is above 30MM, the slope of 30MM is positive! If the price breaks the resistant, It will be in phase 2. But if you take risks, maybe you should buy!

Long

by jlaracena

Published

Waiting for a short on REGN Hi, I am back proposing some ideas. Good trade to all ! Olive_bc

Short

by Olivier_bc

Published

REGN Short Short only below the support line

Short

by ashwinpv9

Published

REGN test regn

by rojackcity

Published

REGN Short Play - Negative Divergence and Fib resistance REGN hitting some resistance here and negative divergence on the RSI. Inside bar with closed with a doji today.

Short

by ashwinpv9

Updated

$REGN 50d/200d Golden Cross $REGN Regeneron Pharma - 50d/200d ema Golden Cross on the daily chart last week after a solid earnings report in early August. Assuming bullish trend line holds, expecting continued gains over the next couple months. Near term target - $391 (gap fill) Medium term target - $420

Long

by Triple_Barrel_Capital

Published

FDA Approves EYLEA® (aflibercept) Injection sBLA REGN: Regeneron Pharmaceuticals, Inc. 2018-08-17 07:00:00 FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

Long

by RocketTickers

Published

Regeneron and Teva Announce Positive Topline Phase 3 TEVA: Teva Pharmaceutical Industries Ltd. 2018-08-16 07:00:00 Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Long

by RocketTickers

Published

REGN- Slowly Bleeding to Death.....CURE TO COME Taking a quick look at the chart and analyzing volume, one can easily see the turnaround is soon to come. Look for a consistent price turnaround in the month of July (2018). The confirmed turnaround should occur early-mid August (2018). What do I know right???

Long

by hesswg48

Updated

11 22 33 44 55 66 77 88 99 1010 1111

…999999

Love in every #TradingView

60M+

Traders and investors use our platform.

Top website in the world when it comes to all things investing.

1.5M+

Mobile reviews with 4.9 average rating. No other fintech apps are more loved.

10M+

Custom scripts and ideas shared by our users.

@chriskane.fx

@neo_inversion

@smart_traderx

@setupstrading

@tradingjunkies.shop

@chuckindex

@noxonfx

@johndollery

@TradingView

@jackentrepreneur

@manithawanii

@WebTrendCo

@anita.febrero

@newcapitalfx

@baldurmedina

@carlosvalenciafx1_

@chartfeed

@bhtrading

Whatever the trade

Here's why Here's why

Products

Supercharts
Pine Script™
Stock Screener
ETF Screener
Forex Screener
Crypto Coins Screener
Crypto Pairs Screener
DEX Pairs Screener
Stock Heatmap
ETF Heatmap
Crypto Heatmap
Economic Calendar
Earnings Calendar
Sparks
News
TradingView Desktop
Mobile app
CME Group futures
Eurex futures
US stocks bundle

Company

About
Features
Pricing
Social network
Wall of Love
Athletes
Manifesto
Careers
Blog
Security vulnerability
Status page
Terms of use
Disclaimer
Privacy policy
Cookies policy
Media kit
Accessibility statement
Tarot cards for traders

Community

Refer a friend
Ideas
Scripts
House rules
Moderators
Pine Script™ Wizards
Chat

For business

Widgets
Advertising
Charting libraries
Lightweight Charts™
Advanced Charts
Trading Platform
Brokerage integration
Partner program
Education program